CA3030163A1 - Recombinant polypeptides comprising selenocysteine and method for producing the same - Google Patents

Recombinant polypeptides comprising selenocysteine and method for producing the same Download PDF

Info

Publication number
CA3030163A1
CA3030163A1 CA3030163A CA3030163A CA3030163A1 CA 3030163 A1 CA3030163 A1 CA 3030163A1 CA 3030163 A CA3030163 A CA 3030163A CA 3030163 A CA3030163 A CA 3030163A CA 3030163 A1 CA3030163 A1 CA 3030163A1
Authority
CA
Canada
Prior art keywords
substitution
position corresponding
seq
polypeptide
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3030163A
Other languages
English (en)
French (fr)
Inventor
Andrew D. Ellington
Ross Thyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System filed Critical University of Texas System
Publication of CA3030163A1 publication Critical patent/CA3030163A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/86—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185—Escherichia
    • C12R2001/19—Escherichia coli
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Oncology (AREA)
CA3030163A 2016-07-11 2017-07-10 Recombinant polypeptides comprising selenocysteine and method for producing the same Pending CA3030163A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662360745P 2016-07-11 2016-07-11
US62/360,745 2016-07-11
PCT/US2017/041373 WO2018013481A1 (en) 2016-07-11 2017-07-10 Recombinant polypeptides comprising selenocysteine and method for producing the same

Publications (1)

Publication Number Publication Date
CA3030163A1 true CA3030163A1 (en) 2018-01-18

Family

ID=60953318

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3030163A Pending CA3030163A1 (en) 2016-07-11 2017-07-10 Recombinant polypeptides comprising selenocysteine and method for producing the same

Country Status (6)

Country Link
US (1) US11155804B2 (cg-RX-API-DMAC7.html)
EP (1) EP3481945A4 (cg-RX-API-DMAC7.html)
JP (2) JP7269648B2 (cg-RX-API-DMAC7.html)
CN (1) CN109844105A (cg-RX-API-DMAC7.html)
CA (1) CA3030163A1 (cg-RX-API-DMAC7.html)
WO (1) WO2018013481A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018045018A1 (en) * 2016-08-30 2018-03-08 Board Of Regents, The University Of Texas System Production of seleno-biologics in genomically recoded organisms
CN109486802B (zh) * 2018-12-26 2020-08-04 广州白云山拜迪生物医药有限公司 一种酶活提高的青霉素酶突变体及其构建方法
WO2025024577A1 (en) * 2023-07-24 2025-01-30 Board Of Regents, The University Of Texas System Incorporating unnatural amino acids using one pot pure system
CN120158456A (zh) * 2023-10-18 2025-06-17 河南农业大学 玉米ZmmtRF2a基因突变标记、鉴定引物及其在调控籽粒发育中的应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10309193A (ja) * 1997-05-12 1998-11-24 Sankyo Co Ltd 哺乳類セレノシステイン含有タンパク質の大腸菌での製造法
US6849417B1 (en) 1998-04-06 2005-02-01 The United States Of America As Represented By The Department Of Health And Human Services Mammalian selenoprotein differentially expressed in tumor cells
WO2001012657A2 (en) * 1999-08-16 2001-02-22 Karolinska Innovations Ab Methods and means for selenoprotein expression
EP1437410A4 (en) * 2001-09-13 2005-01-26 Juridical Foundation NEW SELENOCYSTEIN CONTAINING PROTEINS
WO2007075438A2 (en) 2005-12-15 2007-07-05 Codon Devices, Inc. Polypeptides comprising unnatural amino acids, methods for their production and uses therefor
KR20090105913A (ko) 2006-11-02 2009-10-07 다니엘 제이 카폰 이동 부분을 갖는 하이브리드 면역글로불린
US20090155255A1 (en) 2007-09-27 2009-06-18 Biogen Idec Ma Inc. Cd23 binding molecules and methods of use thereof
MX338336B (es) 2007-11-20 2016-04-07 Ambrx Inc Polipeptidos de insulina modificados y sus usos.
WO2012100343A1 (en) 2011-01-28 2012-08-02 National Research Council Of Canada Engineering of immunoglobulin domains
HUE043894T2 (hu) 2011-06-10 2019-09-30 Bioverativ Therapeutics Inc Koagulációt elõsegítõ vegyületek és alkalmazásuk módszerei
US10876142B2 (en) 2011-07-11 2020-12-29 Yale University Compositions and methods for making selenocysteine containing polypeptides
US9464288B2 (en) * 2011-07-11 2016-10-11 Yale University Compositions and methods for making selenocysteine containing polypeptides
US10240158B2 (en) 2011-07-11 2019-03-26 Yale University Compositions and methods for making selenocysteine containing polypeptides
EP2970505A4 (en) 2013-03-14 2016-10-19 California Inst Biomedical Res SPECIFIC ANTIBODIES AND USES THEREOF
US20150050682A1 (en) * 2013-08-15 2015-02-19 University Of Vermont And State Agricultural College Direct assay of thioredoxin reductase activity
US10519247B2 (en) 2013-11-01 2019-12-31 Board Of Regents,The University Of Texas System Targeting HER2 and HER3 with bispecific antibodies in cancerous cells
US10118950B2 (en) 2014-08-30 2018-11-06 Northwestern University Platforms for cell-free protein synthesis comprising extracts from genomically recoded E. coli strains having genetic knock-out mutations in release factor 1 (RF-1) and endA
WO2016172269A2 (en) 2015-04-20 2016-10-27 University Of Utah Research Foundation Insulin analogs having shortened b chain peptides and associated methods
US10557160B2 (en) * 2015-12-15 2020-02-11 Board Of Regents, The University Of Texas System Transgenic bacteria with expanded amino acid usage and nucleic acid molecules for use in the same
CA3030930A1 (en) 2016-07-22 2018-01-25 University Of Utah Research Foundation Insulin analogs
WO2018045018A1 (en) 2016-08-30 2018-03-08 Board Of Regents, The University Of Texas System Production of seleno-biologics in genomically recoded organisms

Also Published As

Publication number Publication date
WO2018013481A1 (en) 2018-01-18
JP7269648B2 (ja) 2023-05-09
US20190316110A1 (en) 2019-10-17
EP3481945A1 (en) 2019-05-15
JP2019520083A (ja) 2019-07-18
CN109844105A (zh) 2019-06-04
EP3481945A4 (en) 2020-07-29
US11155804B2 (en) 2021-10-26
JP2023060001A (ja) 2023-04-27

Similar Documents

Publication Publication Date Title
US20220389054A1 (en) Polypeptide modification method for purifying polypeptide multimers
JP6932693B2 (ja) カッパ及びラムダ軽鎖を含む抗原結合ポリペプチド構築物及びその使用
KR102168733B1 (ko) 중쇄와 경쇄의 회합이 제어된 항원 결합 분자
CN103429737B (zh) 细胞毒诱导治疗剂
JP2023060001A (ja) セレノシステインを含む組換えポリペプチド及びその製造方法
CN116041516A (zh) 全人源的抗b细胞成熟抗原(bcma)单链抗体及其应用
US20230303694A1 (en) Antibodies that bind gamma-delta t cell receptors
US10927164B2 (en) Method for protein purification
CN119630697A (zh) Ph依赖性hsa结合分子及使用方法
JP2020114217A (ja) ＦｃＲｎ相互作用が変更された抗体を選択するための方法
US12428496B2 (en) Antibodies, compositions for use in detecting or capturing a polypeptide in a sample, and methods for detecting or capturing a polypeptide in a sample
HK40008291A (en) Recombinant polypeptides comprising selenocysteine and method for producing the same
CN115956124A (zh) 改善蛋白质表达的方法
US12516106B2 (en) Method for protein purification
EP4292609A1 (en) Compositions comprising antibodies that bind gamma-delta t cell receptors
JP2022060048A (ja) 抗体及びその使用
RU2779602C2 (ru) Устойчивые мультиспецифические антитела
CN120424216A (zh) 一种抗cd123抗体及其用途
WO2025086263A1 (zh) 抗Taq DNA聚合酶单克隆抗体及其应用
CN117999286A (zh) 用于治疗癌症的CD33 x Vδ2多特异性抗体
HK1188254A (en) Cytotoxicity-inducing therapeutic agent

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20220425

EEER Examination request

Effective date: 20220425

EEER Examination request

Effective date: 20220425

EEER Examination request

Effective date: 20220425

EEER Examination request

Effective date: 20220425

EEER Examination request

Effective date: 20220425

EEER Examination request

Effective date: 20220425

EEER Examination request

Effective date: 20220425